2024 Speaker Faculty

Choose Your Top Tracks & Sessions Here to See Who Was Presenting in 2024!

Workshop
Day
Cell Therapy Fundamentals Day
Investment & Strategy Bootcamp
Tackling Solid Tumors
Focus Day
Automation & Manufacturing Focus Day
Plenary Sessions
Discovery
Track
Translation
Track
Clinical Development Track
Early-Stage Manufacturing Track
Late-Stage Manufacturing Track
Analytical Development Track
Supply Chain & Clinical Operations Track
CAR-TCR Advisory Board

Workshop Day Speakers

Daniel MacLeod

Senior Vice President - Discovery

Immunoscape

Ekatherina Goryachikov

Vp

Adicet Bio Inc.

Elizabeth Wood

Founder & Chief Executive Officer

JURA Bio, Inc.

Gwen Binder

President, Science & Technology

Cabaletta Bio

Howard Wu

Co-Founder & Chief Scientific Officer

Full Circles Therapeutics

LJ Shen

Senior Vice President Head of Research & Development

Gracell

Marc-Olivier Mignon

Chief Commercial Officer

SEQENS

Marcus Calkins

Director, Scientific Communication

GenomeFrontier Therapeutics

Maxwell Wang

Founder & Chief Executive Officer

Skye Medicine

Nik Sgourakis

PI

Children's Hospital of Philadelphia

Samuel Williams

Vice President

Arsenal Bio

Sareina Wu

Chief Scientific Officer

GenomeFrontier Therapeutics

Shon Green

Vice President, Nonclinical Development

Adicet Bio Inc.

Simon Bornschein

Founder & Chief Executive Officer

Coding bio

Sunetra Biswas

Senior Director

Kyverna Therapeutics, Inc.

Tony Arulanandam

CEO and Founder

Synaptimmune Therapeutics

Back To Top

Cell Therapy Fundamentals Day Speakers

Cameron Gardner

Director, Research & Development

JURA Bio

David Sourdive

Co-Founder & Executive Vice President, CMC & Manufacturing

Cellectis Stem Cells

Elisa Kieback

Co-Founder & Chief Technology Officer

T-knife Therapeutics

Haig Aghajanian

Co-Founder, Vice President & Head of Research

Capstan Therapeutics

Jennifer Bolsée

R&D Lead Scientist

Celyad

Mark Dudley

Chief Scientific Officer

InstilBio UK

Raphael Ognar

President & Chief Executive Officer, Co-Founder

NKILT Therapeutics

Stefanos Theoharis

Chief Executive Officer

OneChain Immunotherapeutics

Tom Wickham

Chief Scientific Officer

GentiBio

Ying Li

Director - Early Commercial Strategy

Kite Pharma Inc

Back To Top

Investment & Strategy Bootcamp Speakers

Alex Cogdill

Executive Director, Global BD

Daiichi Sankyo

Arun Pores Fernando

Director, Business Development, Search & Evaluation, Cell Therapy

Bristol Myers Squibb

Efe Egharevba

Executive Director, Product Team Leader

Kite Pharma

Gadi Bornstein

Senior Director - External Innovation, Discovery, Product Development & Supply

Johnson & Johnson Innovative Medicine

Jakob Dupont

Executive Partner

Sofinnova Investments

Jie Zhang

Global Value & Access

Novartis

Jill Goldstein

Senior Associate

Vida Ventures

Justin Zelin

Director, Biotechnology Research Analyst

BTIG

Mojca Skoberne

Entrepreneur in Residence

Google Ventures

Natalia Ulyanova

Director - Business Development & Oncology

Astellas Pharma

Patrick Rivers

Partner | Portfolio Manager

AMoon Fund

Raphael Ognar

President & Chief Executive Officer, Co-Founder

NKILT Therapeutics

Renaud Vaillant

Founder & President

Alaya.bio

Sean Evans

Senior Associate, Venture Investments

Johnson & Johnson Innovative Medicine

Steve Liapis

Director

Northpond Ventures

Thomas Vickers

Account Manager

Beacon Targeted Therapies

Back To Top

C-Level Think Tank

Adrian Bot

Chief Scientific Officer, Executive Vice President, Research & Development

Capstan Therapeutics

Peggy Sotiropoulou

Chief Scientific Officer

T-knife Therapeutics

Back To Top

Driving Diversity in CAR-TCR

Efe Egharevba

Executive Director, Product Team Leader

Kite Pharma

Rolondo Enoch

Director, Head of Diversity & Inclusion in Clinical Trials

Kite Pharma

Back To Top

Plenary Speakers

Adrian Bot

Chief Scientific Officer, Executive Vice President, Research & Development

Capstan Therapeutics

Allen Feng

Founder & Chief Scientific Officer

HebeCell Corp

Andy Kinley

Vice President, Innovation & Clinical Science

Precision for Medicine

Anne Brooks

Senior Vice President & Head of Commercial

Iovance Biotherapeutics

Anshul Mangal

President

Project Farma

Behnam Ahmadian Baghbaderani

Vice President, Sales & Program Management

Lonza

Bruce Levine

Barbara & Edward Netter Professor in Cancer Gene Therapy & Center for Cellular Immunotherapies, Director of Technology Innovation

University of Pennsylvania

Carl June

Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies

University of Pennsylvania

Cassandra Moran

Division of Clinical Evaluation Hematology, Center for Biologics Evaluation & Research

FDA

Chris Jewell

Chief Scientific Officer

Cartesian Therapeutics

Cintia Piccina

Chief Commercial Officer

Adaptimmune

Dan Kirby

Chief Commercial Officer

Orca Bio

Fabian Gerlinghaus

Co-Founder & Chief Executive Officer

Cellares

George Eastwood

Board Chair & Interim Executive Director

Whitehead Foundation

Gwen Binder

President, Science & Technology

Cabaletta Bio

Isabella Maxton

Senior Program Director

Hanson Wade

Jodie Potter

Board Member

Emily Whitehead Foundation

John Lunger

Chief Patient Supply Officer

Adaptimmune

Joseph Garrity

Senior Director, Customer Proposals

Lonza

Kristin Yarema

President & Chief Executive Officer

Poseida Therapeutics

Marcela Maus

Director, Cellular Immunotherapy

Harvard Medical School

Maxwell Wang

Founder & Chief Executive Officer

Skye Medicine

Mazen Karaman

Director, Platform Management of Cell Therapy

Resilience

Milos Miljkovic

Chief Medical Officer

Cartesian Therapeutics

Mindy Miller

Manager Senior Scientist

Terumo Blood & Cell Technologies

Pascal Touchon

President & Chief Executive Officer

Atara Biotherapeutics

Peggy Sotiropoulou

Chief Scientific Officer

T-knife Therapeutics

Regina Young

Scientific Director, June Academic Lab, Center for Cellular Immunotherapies

University of Pennsylvania

Robert Ang

Chief Executive Officer

Vor Bio

Sarah Yuan

Chief Technology Officer

Cabaletta Bio

Shashi Koduru

Senior Director, Business Development

Vector BioMed

Stephanie Goff

Head, Clinical Operations for SB cGMP Facilities Senior Research Physician, Rosenberg Lab

National Cancer Institute

Steve Gavel

Senior Vice President, Commercial Development

Legend Biotech

Back To Top

Discovery Track Speakers

Adrian Bot

Chief Scientific Officer, Executive Vice President, Research & Development

Capstan Therapeutics

Amrik Singh

Senior Fellow, Immunology Product Design & Strategy

Cell Signaling Technology

Daniel Shelly

Chief Business Development Officer

PolTREG

Erika von Euw

Vice President, Discovery & Translational Research 

Deverra Therapeutics

Gemma Moiset

Senior Group Leader, Biotherapeutics Drug Discovery

Charles River Laboratories

Henri Bayle

Chief Technology & Development Officer, Co-Founder

NKILT Therapeutics

John Hadden

Chief Executive Officer

ViroCell

Luke Pase

Chief Technology Officer

Anocca

Marcus Calkins

Director, Scientific Communication

GenomeFrontier Therapeutics

Maurits Geerlings

President & Chief Executive Officer

NanoCell Therapeutics

Musheng Bao

Head of Biology

Nona Biosciences

Robert Mabry

Chief Scientific Officer

Orna Therapeutics

Ryan Crisman

Co-Founder & Chief Technology Officer

Umoja Biopharma

Samik Basu

Chief Scientific Officer

Cabelleta Bio

Tony Arulanandam

CEO and Founder

Synaptimmune Therapeutics

Back To Top

Translation Track Speakers

Aimee Chiavari

Global Biopharma Segment Manager, Cell & Gene Therapy

Agilent Technologies

Blake Aftab

Chief Scientific Officer

Adicet Bio

Christopher Murriel

Vice President, Pre-Clinical Pharmacology

Arsenal Bio

Efi Papalexi

Staff Scientist

Parse Biosciences

Jenell Volkov

Senior Director & Head, Translational Medicine

Cabaletta Bio

Leanne Flye

Associate Director, Scientific Operations, General Laboratory

Labcorp

Patrick Halvey

Director Clinical Biomarker Development, Precision & Translational Medicine

Affini-T Therapeutics

Peggy Sotiropoulou

Chief Scientific Officer

T-knife Therapeutics

Rachel East

Research Analyst

Beacon

Rudolf Übelhart

Chief Scientific Officer

Vanudis

Sarah Hein

Co-Founder & Chief Executive Officer

March Biosciences

Sunil Acharya

Principal Research Scientist

Rezvani Lab, MD Anderson Cancer Center

Vicki Plaks

Global Head of Cell Therapy, Translational Research

Johnson & Johnson

Back To Top

Clinical Development Track Speakers

Abhi Gupta

Senior Vice President, Head of Cell & Gene Therapy

Syneos Health

Ashley Hammad

Executive Director, Clinical Sciences

Poseida Therapeutics

Bruce Levine

Barbara & Edward Netter Professor in Cancer Gene Therapy & Center for Cellular Immunotherapies, Director of Technology Innovation

University of Pennsylvania

Crystal Walsh

Director, Consulting

Syneos Health

Delfi Krishna

Vice President, Technical

Immatics

Hosein Kouros-Mehr

Vice President, Oncology & Head of Clinical Development

TriArm Therapeutics

Kendra Keough

Vice President, Therapeutic Strategy and Innovation, Immunology

Syneos Health

Monet Stanford

Director, Access & Reimbursement Policy

Alliance for Regenerative Medicine

Moonsoo M. Jin

Vice Chair of Research, Department of Radiology

Houston Methodist Research Institute

Mythili Koneru

Chief Medical Officer

Legend Biotech

Pascal Touchon

President & Chief Executive Officer

Atara Biotherapeutics

Patrick Kelly

Vice President, Medical Management

Syneos Health

Patrick Melvin

Vice President, Therapeutic Strategy and Innovation, Oncology

Syneos Health

Raffaele Baffa

Chief Medical Officer

CARsgen Therapeutics

Shrikanta Chattopadhyay

Senior Vice President & Head of Translational Medicine

TScan Therapeutics

Stephanie Goff

Head, Clinical Operations for SB cGMP Facilities Senior Research Physician, Rosenberg Lab

National Cancer Institute

Syed Rizvi

Chief Medical Officer

Poseida Therapeutics

Wendy Li

Chief Medical Officer

EXUMA Biotech

Yongke Zhang

Chief Scientific Officer

IASO Biotherapeutics

Back To Top

Early-Stage Manufacturing Track Speakers

Ali Mohamed

Senior Vice President - Chemistry, Manufacturing & Controls

Immatics GmbH

Andrew Applebury

Associate Director, Process Engineering

Fujifilm Diosnyth Biotechnologies

Catherine Tomaro-Duchesneau

Senior Director, Manufacturing & MS&T

Roslin CT

Cécile Bauche

Chief Scientific Officer

Alaya.bio

Christian Aguilera-Sandoval

Associate Director of Scientific Affairs

Accellix

Damien Hallet

Vice President, CMC

Affini-T Therapeutics

Felix Montero

Global Senior Scientific Director

bioMerieux

George Todorov

Senior Engineer, Process

IPS

Justin McCue

Chief Technology Officer

TScan Therapeutics

Justin Skoble

Vice President, Technical Operations

Caribou Biosciences

Keith Wilson

Director, Manufacturing Science & Technology

Century Therapeutics

Luke Pase

Chief Technology Officer

Anocca

Mamta Kalra

Vice President, CMC, Process & Analytical Development

Immatics

Matthew Hewitt

Vice President, Technical Officer CGT & Biologics

Charles River Laboratories

Melissa van Pel

Head of Cell Therapy

NecstGen

Michelle Andraza

Director, Global Quality Assurance & Chemistry, Manufacturing & Controls

EXUMA Biotechnology

Neil Blackburn

Senior Director, Process Development & Analytics

OmniaBio

Qi Wei

Senior Vice President, Head of Technical Operations

Appia Bio

Tamara Laskowski

Senior Director, Global Head of Autologous Platform

Lonza

Back To Top

Late-Stage Manufacturing Track Speakers

Aaron Vernon

Chief Manufacturing Officer

Quell Therapeutics

Andrew Snowden

Senior Director, Allogeneic & Autologous Cell Therapy Development

Johnson & Johnson

Chithkala Harinarayan

Executive Director & Head, Clinical GMP Quality

Kite Pharma

David Sourdive

Co-Founder & Executive Vice President, CMC & Manufacturing

Cellectis Stem Cells

Ignacio Nunez

Chief Operations Officer

CellReady

Jacob Greenwood

Vice President

Project Farma

Jeroen Bekaert

Co-Founder & Chief Operating Officer

Orca Bio

Justin Skoble

Vice President, Technical Operations

Caribou Biosciences

Katie Jorgensen

BaseCamp Waltham Site Head

Elevate Bio

Ken Harris

Chief Strategy Officer & Head of AI

OmniaBio

Loren Wagner

Chief Operations Officer

Poseida Therapeutics

Marcella Goodnight

Senior Director, MSAT

BioNTech

Mark Stielow

Vice President, Manufacturing & Technical Operations

Adaptimmune

Michelle Andraza

Director, Global Quality Assurance & Chemistry, Manufacturing & Controls

EXUMA Biotechnology

Nelly Viseux

Vice President, Cell Therapies Development, Manufacturing, Supply & Quality

Regeneron Cell Medicines

Rob Collison

US & Canada Cell Therapy Leader

Cytiva

Sara Mills

Head of Cell Therapy CMC

Dark Horse Consulting

Sonia Bulsara

Global CT FAS Team Leader

Cytiva

Vicki Mi

Director, Business Development

Eureka Biotechnology

Back To Top

Analytical Development Track Speakers

Anusuya Hazarika

Associate Director, Quality Control Microbiology

Takeda

Briti Saha

Senior Scientist, Analytical Sciences & Technology

Century Therapeutics

Chien-Chung Chen

Director, Analytical Development

Cabaletta Bio

Cynthia Martino

Director, Research Development Molecular Diagnostics

Bionique Testing Laboratories

Haixia Wang

Head of Analytical Development

Arsenal Bio

Heather Malicki

Executive Director, Analytical Development & Quality Control

WuXi Advanced Therapies

Jie Wei

Director, Bioanalytical Sciences

Tr1x Therapeutics

Mamta Kalra

Vice President, CMC, Process & Analytical Development

Immatics

Oscar Onyema

Independent Expert

Formerly at Precigen

Oyuntyua Munkhbat

Associate Director, Analytical Development

Accellix

Sean Hart

Chief Scientific Officer

LumaCyte

Seraphin Kuate

Director, Global CMC Regulatory, CAR-T Cell Therapy

Bristol Myers Squibb

Vaibhav Patel

Director of Quality Assurance & Regulatory Affairs

University of Minnesotta

Back To Top

Supply Chain & Clinical Operations Track Speakers

Amanda Hrnicek

Senior Director, Authorized Treatment Center Cell Therapy Operations

Lovance Biotherapeutics

Amy Emmert

Executive Director, Cell Therapy Facility

Dana Farber Cancer Institute

Ekatherina Goryachikov

Vp

Adicet Bio Inc.

Ignacio Nunez

Chief Operations Officer

CellReady

John Lunger

Chief Patient Supply Officer

Adaptimmune

Karen Moniz

Technical Director

ICCBBA

Kirstin Liechty

Senior Director, Clinical Operations

A2 Biotherapeutics

Laura Deschenes

Vice President & Head of Supply Chain

Sana Biotechnology

Ryan Crisman

Co-Founder & Chief Technology Officer

Umoja Biopharma

Y. Morris Chen

Cell & Gene Therapy Lead, Research & Development IT

AstraZeneca

Yuki Kato Maves

Associate Director, Product Management

Discovery Life Sciences (AllCells®)

Back To Top

Tackling Solid Tumors Focus Day Speakers

Francesca Barone, MD, PhD

Chief Scientific Officer

Candel Therapeutics

Gary Shapiro

Vice President Discovery Biology

Affini-T Therapeutics

Mariam Mansour

Senior Director Clinical development and Translational sciences

Prescient Therapeutics Pty Ltd

Matthias Schroff

Chief Executive Officer

Inceptor Bio

Micah Benson

Chief Scientific Officer

KSQ Therapeautics

Nayan Jain

Research Fellow, Sadelain Lab

Memorial Sloan Kettering Cancer Center

Parameswaran Hari

CDO

Obsidian Therapeutics

Tony Arulanandam

CEO and Founder

Synaptimmune Therapeutics

Back To Top

Automation & Manufacturing Technology Focus Day Speakers

Ali Mohamed

Senior Vice President - Chemistry, Manufacturing & Controls

Immatics GmbH

Bassem Gayed

Senior Director - Technical Process Engineering CAR-T Manufacturing Science and Technology

Celgene

Fabio Fachin

Executive Director - Cell Therapy

Takeda

Lilly Wollman

Chief Executive Officer

Synteny

Raymond Luke

Director & Head of Manufacturing Science, Technology, Chemistry, Manufacturing, & Controls

Verismo Therapeutics

Therese Choquette

Head of Analytical and Translational Sciences

Tigen Pharma

Back To Top

CAR-TCR Advisory Board

Bruce Levine

Barbara & Edward Netter Professor in Cancer Gene Therapy & Center for Cellular Immunotherapies, Director of Technology Innovation

University of Pennsylvania

Kristin Yarema

President & Chief Executive Officer

Poseida Therapeutics

Mark Dudley

Chief Scientific Officer

InstilBio UK

Samik Basu

Chief Scientific Officer

Cabelleta Bio

2024 AGENDA
REGISTER INTEREST
PARTNER